ASAN FOUNDATION
- Country
- 🇰🇷South Korea
- Ownership
- Private
- Established
- 1989-06-23
- Employees
- 501
- Market Cap
- -
- Website
- https://ails.amc.seoul.kr
Effect of Thrombin-containing Collagen-based Hemostatic Matrix
- Conditions
- Pancreatic Tumor
- Interventions
- Drug: flowable thrombin containing collagen hemostat matrix
- First Posted Date
- 2020-04-22
- Last Posted Date
- 2020-04-28
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 60
- Registration Number
- NCT04357483
- Locations
- 🇰🇷
Asan medical center, Seoul, Korea, Republic of
Home-based Cognitive Monitoring in MCI
- Conditions
- Mild Cognitive Impairment
- Interventions
- Diagnostic Test: home-based cognitive monitoring
- First Posted Date
- 2020-04-17
- Last Posted Date
- 2020-04-20
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 40
- Registration Number
- NCT04350801
- Locations
- 🇰🇷
Uijeongbu St. Mary's hospital, Uijeongbu, Korea, Republic of
Pharmacological Reduction of Right Ventricular Enlargement
- Conditions
- Tricuspid RegurgitationRight Ventricular Dilatation
- Interventions
- First Posted Date
- 2020-04-14
- Last Posted Date
- 2025-04-06
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 56
- Registration Number
- NCT04345796
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of
🇰🇷Samsung Medical Center, Seoul, Korea, Republic of
🇰🇷Seoul National University Hospital, Seoul, Korea, Republic of
Analysis of the Microbiome in the Healthy Smokers and COPD Patients
- Conditions
- Pulmonary Disease, Chronic ObstructiveMicrobiota
- Interventions
- Diagnostic Test: Obtain samples from sputum and feces
- First Posted Date
- 2020-04-07
- Last Posted Date
- 2020-04-07
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 60
- Registration Number
- NCT04336423
- Locations
- 🇰🇷
Department of Pulmonary and Critical Care Medicine and Clinical Research Center for Chronic Obstructive Airway Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of
Von Willebrand Factor and Protein C Ratio in Graft Function After Liver Transplant
- Conditions
- Liver Transplant; Complications
- Interventions
- Procedure: LT
- First Posted Date
- 2020-03-27
- Last Posted Date
- 2020-03-27
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 1199
- Registration Number
- NCT04324255
- Locations
- 🇰🇷
Asan Medical center, Seoul, Korea, Republic of
B-line by Lung US in Patients With Acute Decompensated Heart Failure
- Conditions
- Heart Failure
- Interventions
- Diagnostic Test: Lung ultrasound
- First Posted Date
- 2020-03-26
- Last Posted Date
- 2023-02-02
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 300
- Registration Number
- NCT04322851
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of
MR-target Biopsy vs. TRUS-biopsy in Men With Suspicious Prostate Cancer
- Conditions
- Prostate Cancer
- Interventions
- Device: Artemia
- First Posted Date
- 2020-03-24
- Last Posted Date
- 2020-03-25
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 300
- Registration Number
- NCT04320147
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of
Combination of Regorafenib and Nivolumab in Unresectable Hepatocellular Carcinoma
- Conditions
- HepatomaCarcinoma, Hepatocellular
- Interventions
- Drug: Regorafenib/Nivolumab
- First Posted Date
- 2020-03-17
- Last Posted Date
- 2022-12-06
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 42
- Registration Number
- NCT04310709
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of
🇰🇷Samsung Medical Center, Seoul, Korea, Republic of
🇰🇷Bundang CHA Hospital, Seongnam, Korea, Republic of
A Study of Trastuzumab in Combination With Capecitabine and Cisplatin in Patients With Tissue HER2- But Serum HER2+ AGC
- Conditions
- Gastric or Gastroesophageal Junction(GEJ) Adenocarcinoma
- Interventions
- Drug: Trastuzumab, Capecitabine and Cisplatin
- First Posted Date
- 2020-03-16
- Last Posted Date
- 2024-02-28
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 28
- Registration Number
- NCT04309578
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of
Comparison of Lopinavir/Ritonavir or Hydroxychloroquine in Patients With Mild Coronavirus Disease (COVID-19)
- Conditions
- COVID-19
- Interventions
- First Posted Date
- 2020-03-13
- Last Posted Date
- 2020-05-27
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 65
- Registration Number
- NCT04307693
- Locations
- 🇰🇷
Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of